Quarterly report · Q2
7681.TEDINET S100QQRD
Period2022-10-01 → 2023-03-31
Filed2023-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.7bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥29.8bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥18.8bn | 2021-10-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥263m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥771m | 2021-10-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥249m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥710m | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥824m | 2021-10-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥249m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥824m | 2021-10-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥144m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥437m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥546m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥154m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥573m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥15.3bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥13.5bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥16.1bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥9.8bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.9bn | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥5.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.5bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.6bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.5bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.5bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.0bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.4bn | at 2021-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥219m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥242m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥742m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥55m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥50m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥34m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥118m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥121m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥111m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥73.31 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.68 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥222.9 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥278.45 | 2021-10-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥80.49 | 2022-01-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥73.09 | 2022-10-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥221.52 | 2021-10-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥277.57 | 2021-10-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 35.4% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.0% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | ¥1m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥205m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥205m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥4m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥362m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥362m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥39m |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥11.1bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥11.1bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥219m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-10-01 → 2023-03-31 | ¥11.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-10-01 → 2023-03-31 | ¥11.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-10-01 → 2023-03-31 | ¥262m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-03-31 | ¥1m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥199m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥199m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | segment profit | 2021-10-01 → 2022-03-31 | ¥4m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥332m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥332m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | ¥41m |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥18.2bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥18.2bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | ¥725m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-10-01 → 2022-03-31 | ¥18.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-10-01 → 2022-03-31 | ¥18.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-10-01 → 2022-03-31 | ¥770m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 498
| Item | Context | Value | Unit |
|---|---|---|---|
| Provision for directors retirement benefits | Prior1YearInstant | 435055000 | JPY |
| Provision for directors retirement benefits | CurrentQuarterInstant | 424805000 | JPY |
| Other ncl | Prior1YearInstant | 90248000 | JPY |
| Other ncl | CurrentQuarterInstant | 89573000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 912248000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 851891000 | JPY |
| Liabilities | Prior1YearInstant | 7930211000 | JPY |
| Liabilities | CurrentQuarterInstant | 9752372000 | JPY |
| Capital stock | Prior1YearInstant | 539369000 | JPY |
| Capital stock | CurrentQuarterInstant | 539369000 | JPY |
| Capital surplus | Prior1YearInstant | 498944000 | JPY |
| Capital surplus | CurrentQuarterInstant | 498944000 | JPY |
| Retained earnings | Prior1YearInstant | 4242579000 | JPY |
| Retained earnings | CurrentQuarterInstant | 4288281000 | JPY |
| Treasury stock | Prior1YearInstant | -166000 | JPY |
| Treasury stock | CurrentQuarterInstant | -166000 | JPY |
| Shareholders equity | Prior1YearInstant | 5280727000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 5326429000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 103893000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 101658000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 103893000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 101658000 | JPY |
| Non controlling interests | Prior1YearInstant | 153351000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 153724000 | JPY |
| Net assets | Prior1YearInstant | 5537971000 | JPY |
| Net assets | CurrentQuarterInstant | 5581812000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 13468183000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 15334184000 | JPY |
| Net sales | Prior1YTDDuration | 18756539000 | JPY |
| Net sales | CurrentYTDDuration | 11662168000 | JPY |
| Cost of sales | Prior1YTDDuration | 16825785000 | JPY |
| Cost of sales | CurrentYTDDuration | 10236841000 | JPY |
| Gross profit | Prior1YTDDuration | 1930754000 | JPY |
| Gross profit | CurrentYTDDuration | 1425327000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 1159275000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 1162136000 | JPY |
| Operating income | Prior1YTDDuration | 771479000 | JPY |
| Operating income | CurrentYTDDuration | 263190000 | JPY |
| Interest income noi | Prior1YTDDuration | 373000 | JPY |
| Interest income noi | CurrentYTDDuration | 52000 | JPY |
| Dividends income noi | Prior1YTDDuration | 250000 | JPY |
| Dividends income noi | CurrentYTDDuration | 250000 | JPY |
| Insurance premiums refunded cancellation noi | Prior1YTDDuration | 54000000 | JPY |
| Insurance premiums refunded cancellation noi | CurrentYTDDuration | 896000 | JPY |
| Subsidy income noi bounty | Prior1YTDDuration | - | JPY |
| Subsidy income noi bounty | CurrentYTDDuration | 712000 | JPY |
| Other noi | Prior1YTDDuration | 451000 | JPY |
| Other noi | CurrentYTDDuration | 1371000 | JPY |
| Non operating income | Prior1YTDDuration | 55075000 | JPY |
| Non operating income | CurrentYTDDuration | 3283000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |